11-23-2005, 05:24 PM
PediaMed Sponsors Cure Autism Now's WALK NOW Event at Disney World
PediaMed--The Pediatrics Company™, a company specializing in the health and well-being of children, provided support to Cure Autism Now's WALK NOW event this past Saturday, November 19, at Walt Disney's Wide World of Sports Complex in Orlando, Florida. The event raised over $100,000 uniting families and supporters in an effort to increase public awareness and help the more than 1.5 million Americans(1) living with autism.
"Our involvement with Cure Autism Now and experience in this therapeutic area has afforded us a unique understanding of the daily challenges and needs faced by families living with autism," says Dr. Cameron Durrant, President and CEO of PediaMed. "We are pleased and honored to have been a part of this event and hope that our continued work in this arena will have a positive effect on families living with autism."
PediaMed is currently sponsoring a study that is exploring the effect of an investigational drug on gastrointestinal (GI) dysfunction, which may affect up to 50 percent of children with autism. There is increasing scientific evidence that there may be a link between GI problems and the underlying behavioral changes associated with autism. As a result, health care professionals are beginning to look beyond medicines that work with the brain and explore treatments that address both the GI symptoms and the behavioral symptoms.
Autism is the most common of the Pervasive Developmental Disorders, affecting an estimated 1 in 166 births (Centers for Disease Control and Prevention, 2005) and is believed to be growing at a rate of 10 to 17 percent per year.
WALK NOW is a 5K event that includes an autism community resource fair where parents can meet a variety of autism service providers while kids enjoy arts & crafts, moon bounces and other fun activities. Proceeds from WALK NOW support Cure Autism Now's mission to find the causes, effective treatments, and a cure for autism.
About PediaMed - The Pediatrics Company™
PediaMed Pharmaceuticals, Inc. - The Pediatrics Company™ is a privately held, specialty pharmaceutical company focused on providing safe and effective medicine to pediatric patients, parents and the healthcare professionals that serve them. In just a few short years the company has been able to establish a 100-plus-person sales and marketing team and achieve profitability. The company has also established a significant development pipeline and has extensive pediatric clinical development and regulatory expertise. Net sales have quadrupled in the last two years.
PediaMed today focuses on providing Kidpliant™ prescription medicines in the field of allergy/cough/cold and in promoting TAZORAC® (tazarotene) acne cream and gel, ZYMAR® (gatifloxacin ophthalmic solution), and CLARINEX® (desloratadine) Syrup and Tablets, through recently established co-marketing arrangements with Allergan and Schering-Plough Corporation. In keeping with its mission, the company is identifying underserved pediatric market opportunities in the areas of respiratory/ allergy, anti-infectives, gastroenterology, dermatology and central nervous system (CNS). The company is in the process of acquiring new products/opportunities to leverage its core sales and marketing competency focused in the highly underserved and rapidly growing pediatric market.
With recent changes in the regulatory landscape regarding pediatric pharmaceuticals, the company believes that the opportunities are many and growing, and it is well positioned to take full advantage of these opportunities with pediatrics now established as one of the fastest growing prescription segments.
Founded in 1999 and with commercial operations commencing in March 2001, PediaMed is a member of the Union Springs, L.L.C. portfolio of companies, who alongside Essex-Woodlands Health Ventures and Blue Chip Venture Company are key investors. For more information, visit the PediaMed Web site at http://www.pediamedpharma.com.
About Cure Autism Now
Cure Autism Now is a non-profit organization dedicated to promoting and funding autism research and accelerating the pace of scientific progress toward effective treatments and a cure for autism. The organization is one of the leading private funders of biomedical research in autism, providing more than $25 million for research grants, education, outreach and scientific resources, including the establishment and ongoing support of the Autism Genetic Resource Exchange (AGRE). Cure Autism Now has chapters in Atlanta, Boston, Chicago, Hawaii, Houston, Los Angeles, Michigan, New Jersey, New York, Orange County, Orlando, Philadelphia, San Diego, San Francisco, Seattle, and Washington DC/Baltimore. For more information about Cure Autism Now, please visit http://www.cureautismnow.org.
(1)Autism Society of America - http://www.autism-society.org/site/PageS...atisAutism
Source: Red Orbit Breaking News
http://www.redorbit.com/news/health/3124...e=r_health
*************************************************************
PediaMed--The Pediatrics Company™, a company specializing in the health and well-being of children, provided support to Cure Autism Now's WALK NOW event this past Saturday, November 19, at Walt Disney's Wide World of Sports Complex in Orlando, Florida. The event raised over $100,000 uniting families and supporters in an effort to increase public awareness and help the more than 1.5 million Americans(1) living with autism.
"Our involvement with Cure Autism Now and experience in this therapeutic area has afforded us a unique understanding of the daily challenges and needs faced by families living with autism," says Dr. Cameron Durrant, President and CEO of PediaMed. "We are pleased and honored to have been a part of this event and hope that our continued work in this arena will have a positive effect on families living with autism."
PediaMed is currently sponsoring a study that is exploring the effect of an investigational drug on gastrointestinal (GI) dysfunction, which may affect up to 50 percent of children with autism. There is increasing scientific evidence that there may be a link between GI problems and the underlying behavioral changes associated with autism. As a result, health care professionals are beginning to look beyond medicines that work with the brain and explore treatments that address both the GI symptoms and the behavioral symptoms.
Autism is the most common of the Pervasive Developmental Disorders, affecting an estimated 1 in 166 births (Centers for Disease Control and Prevention, 2005) and is believed to be growing at a rate of 10 to 17 percent per year.
WALK NOW is a 5K event that includes an autism community resource fair where parents can meet a variety of autism service providers while kids enjoy arts & crafts, moon bounces and other fun activities. Proceeds from WALK NOW support Cure Autism Now's mission to find the causes, effective treatments, and a cure for autism.
About PediaMed - The Pediatrics Company™
PediaMed Pharmaceuticals, Inc. - The Pediatrics Company™ is a privately held, specialty pharmaceutical company focused on providing safe and effective medicine to pediatric patients, parents and the healthcare professionals that serve them. In just a few short years the company has been able to establish a 100-plus-person sales and marketing team and achieve profitability. The company has also established a significant development pipeline and has extensive pediatric clinical development and regulatory expertise. Net sales have quadrupled in the last two years.
PediaMed today focuses on providing Kidpliant™ prescription medicines in the field of allergy/cough/cold and in promoting TAZORAC® (tazarotene) acne cream and gel, ZYMAR® (gatifloxacin ophthalmic solution), and CLARINEX® (desloratadine) Syrup and Tablets, through recently established co-marketing arrangements with Allergan and Schering-Plough Corporation. In keeping with its mission, the company is identifying underserved pediatric market opportunities in the areas of respiratory/ allergy, anti-infectives, gastroenterology, dermatology and central nervous system (CNS). The company is in the process of acquiring new products/opportunities to leverage its core sales and marketing competency focused in the highly underserved and rapidly growing pediatric market.
With recent changes in the regulatory landscape regarding pediatric pharmaceuticals, the company believes that the opportunities are many and growing, and it is well positioned to take full advantage of these opportunities with pediatrics now established as one of the fastest growing prescription segments.
Founded in 1999 and with commercial operations commencing in March 2001, PediaMed is a member of the Union Springs, L.L.C. portfolio of companies, who alongside Essex-Woodlands Health Ventures and Blue Chip Venture Company are key investors. For more information, visit the PediaMed Web site at http://www.pediamedpharma.com.
About Cure Autism Now
Cure Autism Now is a non-profit organization dedicated to promoting and funding autism research and accelerating the pace of scientific progress toward effective treatments and a cure for autism. The organization is one of the leading private funders of biomedical research in autism, providing more than $25 million for research grants, education, outreach and scientific resources, including the establishment and ongoing support of the Autism Genetic Resource Exchange (AGRE). Cure Autism Now has chapters in Atlanta, Boston, Chicago, Hawaii, Houston, Los Angeles, Michigan, New Jersey, New York, Orange County, Orlando, Philadelphia, San Diego, San Francisco, Seattle, and Washington DC/Baltimore. For more information about Cure Autism Now, please visit http://www.cureautismnow.org.
(1)Autism Society of America - http://www.autism-society.org/site/PageS...atisAutism
Source: Red Orbit Breaking News
http://www.redorbit.com/news/health/3124...e=r_health
*************************************************************
